Compound ID | 321
Synonym(s): CS-023 | RO4908463 | R-115685
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets. Carbapenems have a very broad spectrum incl. non-fermenters and are not hydrolysed by most beta-lactamases with exception of carbapenemases. |
Institute where first reported: | Daiichi Sankyo Pharmaceutical; Hoffman-La Roche, Switzerland |
Year first mentioned: | 2000 |
Highest developmental phase: | Phase 2 |
Development status: | Inactive |
Reason Dropped: | Discontinued for unknown reasons (LS) |
Chemical structure(s): | |
Canonical SMILES: | C[C@@H]1[C@@H]2[C@@H]([C@@H](C)O)C(=O)N2C(=C1S[C@H]3C[C@@H](C(=O)N4CC[C@@H](C4)NC(=O)CN=C(N)N)N(C)C3)C(=O)O |
Isomeric SMILES: | C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](N(C3)C)C(=O)N4CC[C@@H](C4)NC(=O)CN=C(N)N)C(=O)O)[C@@H](C)O |
InChI: | InChI=1S/C23H35N7O6S/c1-10-17-16(11(2)31)21(34)30(17)18(22(35)36)19(10)37-13-6-14(28(3)9-13)20(33)29-5-4-12(8-29)27-15(32)7-26-23(24)25/h10-14,16-17,31H,4-9H2,1-3H3,(H,27,32)(H,35,36)(H4,24,25,26)/t10-,11-,12+,13+,14+,16-,17-/m1/s1 |
InChI Key: | KEDAXBWZURNCHS-GPODMPQUSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/9809656 |
External links: | |
Guide to Pharmacology: | tomopenem |
Citations: |
|